Volume : 09, Issue : 10, October – 2022

Title:

44.EVALUATION OF ANTICONVULSANT ACTIVITY OF APIUM GRAVEOLENS ON DIFFERENT INDUCING MODELS IN MICE
‬

Authors :

P. Vinay Kumar, M. Meena Kumari

Abstract :

Epilepsy is a chronic CNS disorder characterized by brief episodesof seizures and excessive EEG discharge. The selection of this plant, Apium graveolens was made on the basis of its High therapeutic value, Easy availability, Degree of research work which is not done. Apium graveolens contained appreciable amount of tannins, flavonoids, steroids, saponins, however, terpenoids content was almost negligible. The Ethanol extract of Apium graveolens delayed the onset and reduced the duration of convulsion in MES and PTZ induced convulsion models and can be used as an adjuvant therapy against cognitive deficit in convulsions. The extract also shows significant decrease in lipid peroxidation level and increase in reduced glutathione level, indicates that EAG possess good antioxidant activity. Also, EAG significantly increased the level of inhibitory neurotransmitter GABA and also showed increase in DA, NA and 5-HT levels. Hence it can be concluded that the EAG possesses good anticonvulsant activity. Further studies are needed to explore the mechanism as well as the active principle responsible for the anticonvulsant activity of Apium graveolens.
Key words: Anticonvulsant activity, Apium Graveolens, Mice.

Cite This Article:

References:

1. B. Saraceno, G. Avanzini, P. Lee, Atlas: Epilepsy Care in the World, World Health Organization, 2005.
2. E. Magiorkinis, A. Diamantis, K. Sidiropoulou, C. Panteliadis, Highlights in the History of Epilepsy: the Last 200 Years, Epilepsy research and treatment, 2014, 2014.
3. D.A. Kandawire, The Socio-economic Experiences of People with Epilepsy Employed in the Open Labour Market in the Ekurhuleni Region, University of Pretoria, 2016.
4. C.R. Newton, H.H. Garcia, Epilepsy in poor regions of the world, Lancet 380 (9848) (2012) 1193e1201.
5. G.G. Somjen, Ions in the Brain: normal Function, Seizures, and Stroke, Oxford University Press, 2004.
6. G.K. Bergey, Neurostimulation in the treatment of epilepsy, Exp. Neurol. 244 (2013) 87e95.
7. R.G. Levy, P.N. Cooper, P. Giri, J. Weston, Ketogenic Diet and Other Dietary Treatments for Epilepsy, The Cochrane Library, 2012.
8. Peng Y, Sun J, Hon S, Nylander AN, Xia W, Feng Y, et al. L-3-nbutylphthalide improves cognitive impairment and reduces amyloid-beta in a transgenic model of Alzheimer’s disease. J Neurosci 2010; 30: 8180-9.
9. Sowbhagya HB. Chemistry, technology, and nutraceutical functions of celery (Apium graveolens L.): an overview. Crit Rev Food Sci Nutr 2014; 54(3): 389-98.
10. Uddin Z, Shad AA, Bakht J, Ullah I, Jan S. In vitro antimicrobial, antioxidant activity and phytochemical screening of Apium graveolens. Pak J Pharm Sci 2015; 28: 1699-704.
11. Powanda MC, Whitehouse MW, Rainsford KD. Celery seed and related extracts with antiarthritic, antiulcer, and antimicrobial activities. Prog Drug Res 2015; 70: 133-53.
12. Dianat M, Veisi A, Ahangarpour A, Fathi Moghaddam H. The effect of hydro-alcoholic celery (Apium graveolens) leaf extract on cardiovascular parameters and lipid profile in animal model of hypertension induced by fructose. Avicenna J Phytomed 2015; 5: 203-9.
13. Dr. Shankara Sharma, N.Sriram. Anti-ulcer activity of Simarouba glauca against ethanol and indomethacin induced ulcer in rats. Int.J.of Res.in pharmacology and Pharmacotherapeutics. June 2014; 3(2): 85-89
14. Bhardwaj S, Deepika Gupta. Study of acute, sub scute and chronic toxicity studies. IJARBP. 2012; 2(2): 103-129